Selective Pressures Exerted by the Innate Immune System on Commensals in the Zebrafish Gut
先天免疫系统对斑马鱼肠道共生体施加的选择性压力
基本信息
- 批准号:9051841
- 负责人:
- 金额:$ 5.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-01 至 2019-01-31
- 项目状态:已结题
- 来源:
- 关键词:AeromonasAttenuatedBacteriaBiological AssayBiological ModelsBiological Response Modifier TherapyClostridium difficileColon CarcinomaCommunitiesDevelopmentDiabetes MellitusDiarrheaDiseaseEducational process of instructingEvolutionFutureGastrointestinal tract structureGeneticGenetic DeterminismGenetic ScreeningGnotobioticGoalsHealthHumanImmuneImmune responseImmune systemImmunizationIndividualInflammatory Bowel DiseasesIntestinesKnowledgeMicrobeModelingMono-SMutagenesisMutationNatural ImmunityNatureObesityOrganismProbioticsProtocols documentationRoleSerial PassageShapesStructureSystemTestingVariantVertebratesWorkZebrafishadaptive immunitybacterial fitnesscommensal microbesdesignfitnessgut microbiotaimmunogenicityin vivoinnate immune functioninsightmicrobiotamutantnutritionpathogenpressurepublic health relevancetherapy development
项目摘要
DESCRIPTION (provided by applicant): The significance of the impacts of the intestinal microbiota on human health and disease cannot be overstated. It is undeniable that these microbes are integral to the healthy function of the hosts they colonize. They provide a plethora of beneficial functions including ones impacting nutrition, development of the immune system, and protection from pathogens. However, many diseases are associated with changes in the composition, structure, or function of these communities, including obesity, inflammatory bowel disease, diabetes, colon cancer, and Clostridium difficile-associated diarrhea. Unfortunately, there is not currently a deep enough understanding of the host-microbe and microbe-microbe interactions that govern community structure and function to fully explicate disease development. More importantly, current knowledge is not sufficient to facilitate the development of therapies aimed at restoring healthy function of dysbiotic communities in order to ameliorate disease. Therefore, the overarching goal of this proposal is to expand our knowledge of how the host impacts community assembly and dynamics, and inform us about adaptive strategies of commensal organisms. More specifically, I propose to determine the selective pressures exerted by the host innate immune response during bacterial adaptation to the vertebrate gut. Herein I will test the hypothesis that there is an optimal immunogenicity of commensal bacteria such that adaptation in the presence of a functional innate immune system results in a shift towards this optimum level. To accomplish this, I will use the gnotobiotc zebrafish model to investigate the selective pressures exerted by the host innate immune system during adaption of a natural gut isolate. This is a simple yet powerful model system because it specifically allows
for observation of interactions between the innate immune response and the selected bacterium. Two different approaches will be used to generate variant strains of Aeromonas ZOR0001 (Aer01) that have increased fitness in the zebrafish gut. In AIM 1 a forward genetic screen (Tn-seq) is used to assay the fitness contributions of the entire genetic repertoire of Aer01 to specifically identify mutations that result in increased fitness in vivo. In AIM 2, an adaptive evolution approach is used to compare genetic adaptations conferring increased fitness when evolved in WT versus immunodeficient hosts. Gain-of-fitness mutations identified by each approach will be constructed in the WT ancestral genetic background and their colonization fitness and capacity to stimulate the host immune response assayed. These two approaches allow for an unbiased identification of the genetic determinants of adaptation of Aer01, maximizing the potential to study multiple avenues of bacterial adaptation and the selective pressures exerted by the host innate immune system. The impact of this work is significant because it will provide insights into how the the innate immune system shapes commensal fitness in the vertebrate gut, which is knowledge that can be exploited to precisely manipulate host-associated microbiota and moves us closer to advanced biotherapeutic treatments for dysbiotic diseases.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Catherine Pohl Robinson其他文献
Catherine Pohl Robinson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Catherine Pohl Robinson', 18)}}的其他基金
Aim protein-based anti-inflammatory therapeutic for the treatment of IBD
基于蛋白质的抗炎疗法治疗 IBD
- 批准号:
10822016 - 财政年份:2023
- 资助金额:
$ 5.43万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 5.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 5.43万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 5.43万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 5.43万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 5.43万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 5.43万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 5.43万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 5.43万 - 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 5.43万 - 项目类别:
Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 5.43万 - 项目类别:
Research Grant














{{item.name}}会员




